The rising popularity in GLP-1 agonists for metabolic conditions has generated a debate about delivery methods : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were exclusively https://albieztvp388568.newsbloger.com/41567189/glp-1-transdermal-delivery-systems-vs-tablets-what-right-for-individuals